| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Reilly Thomas Charles (SVP and CFO) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Paid exercise price by delivering 8,209 shares
@ $1.19, valued at
$9.8k
Exercised 16,667 options to buy
@ $0 |
|
| 02/23/2023 |
4
| Reilly Thomas Charles (SVP and CFO) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Granted 269,600 options to buy
@ $1.8, valued at
$485.3k
Granted 134,800 options to buy
@ $0
Granted 50,000 options to buy
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2020 |
4
| Reilly Thomas Charles (CFO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $12.74, valued at
$2.2M
|
|
| 10/07/2020 |
3
| Reilly Thomas Charles (CFO) has filed a Form 3 on Cara Therapeutics, Inc. |